Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with ...

The gold rush to the far reaches of Kansas Territory (Colorado) in 1859 brought tens of thousands of hopeful fortune seekers west from the States. Health and wealth were the ...